Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 2/2018

24.10.2018

Neuroendocrine neoplasms – think about it and choose the most appropriate diagnostic and therapeutic steps

verfasst von: Christian A. Koch, S. Petersenn

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

We are pleased to present the second issue on neuroendocrine neoplasms (NEN). Often, NEN are also referred to as “zebras” because of their rarity, and we would like to expand this thought into “black swans,” a term that is based on an ancient perception that presumed black swans did not exist, but had to be changed once they were discovered in nature. This should teach us that any system of thought should constantly be re-evaluated. It is understandable that humans usually harbor some anxiety towards the unknown and that this angst is more pronounced in more conservative communities than in progressive ones. Discoveries are usually made by thinking “outside of the box.” For instance, excessively high serum calcitonin levels could be alarming for an existing NEN. The odds of a possible NEN would call for a neck examination to search for medullary thyroid carcinoma and in some cases thyroidectomy would be performed without identifying any tumor [1], because calcitonin secretion occurs ectopically from an unsuspected NEN [28]. More recently, the presence of macrocalcitonin as a pitfall in the endocrine laboratory assessment has been discovered [9]. Similar to other macrohormones such as macroprolactin, a macro-thyroid stimulating hormone, macrocalcitonin has neglectable biological activity [911]. …
Literatur
1.
Zurück zum Zitat Johannessen JV, Gould VE. Neuroendocrine skin carcinoma associated with calcitonin production: a Merkel cell carcinoma? Hum Pathol. 1980;11(5 Suppl):586–8.PubMed Johannessen JV, Gould VE. Neuroendocrine skin carcinoma associated with calcitonin production: a Merkel cell carcinoma? Hum Pathol. 1980;11(5 Suppl):586–8.PubMed
2.
Zurück zum Zitat Uccella S, Blank A, Maragliano R, Sessa F, Perren A, La Rosa S. Calcitonin-producing neuroendocrine neoplasms of the pancreas: Clinicopathological study of 25 cases and review of the literature. Endocr Pathol. 2017;28(4):351–61.CrossRef Uccella S, Blank A, Maragliano R, Sessa F, Perren A, La Rosa S. Calcitonin-producing neuroendocrine neoplasms of the pancreas: Clinicopathological study of 25 cases and review of the literature. Endocr Pathol. 2017;28(4):351–61.CrossRef
3.
Zurück zum Zitat Fertig RM, Alperstein A, Diaz C, Klingbeil KD, Vangara SS, Misawa R, et al. Metastatic neuroendocrine tumor of the esophagus with features of medullary thyroid carcinoma. Intractable Rare Dis Res. 2017;6(3):224–9.CrossRef Fertig RM, Alperstein A, Diaz C, Klingbeil KD, Vangara SS, Misawa R, et al. Metastatic neuroendocrine tumor of the esophagus with features of medullary thyroid carcinoma. Intractable Rare Dis Res. 2017;6(3):224–9.CrossRef
4.
Zurück zum Zitat Cvijovic G, Micic D, Kendereski A, Zoric S, Sumarac-Dumanovic M, Tatic S, et al. Ectopic calcitonin secretion in a woman with large cell neuroendocrine lung carcinoma. Hormones (Athens). 2013;12(4):584–90.CrossRef Cvijovic G, Micic D, Kendereski A, Zoric S, Sumarac-Dumanovic M, Tatic S, et al. Ectopic calcitonin secretion in a woman with large cell neuroendocrine lung carcinoma. Hormones (Athens). 2013;12(4):584–90.CrossRef
5.
Zurück zum Zitat Kameya T, Shimosato Y, Adachi I, Abe K, Ebihara S, Ono I. Neuroendocrine carcinoma of the paranasal sinus: a morphological and endocrinological study. Cancer. 1980;45(2):330–9.CrossRef Kameya T, Shimosato Y, Adachi I, Abe K, Ebihara S, Ono I. Neuroendocrine carcinoma of the paranasal sinus: a morphological and endocrinological study. Cancer. 1980;45(2):330–9.CrossRef
6.
Zurück zum Zitat Heath H 3rd, Edis AJ. Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin. Ann Intern Med. 1979;91(2):208–10.CrossRef Heath H 3rd, Edis AJ. Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin. Ann Intern Med. 1979;91(2):208–10.CrossRef
7.
Zurück zum Zitat Vinik A, Perry RR, Casellini C, Hughes MS, Feliberti E. Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2018. https://www.ncbi.nlm.nih.gov/books/NBK279074/. Vinik A, Perry RR, Casellini C, Hughes MS, Feliberti E. Pathophysiology and Treatment of Pancreatic Neuroendocrine Tumors (PNETs): New Developments. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2018. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK279074/​.
8.
Zurück zum Zitat Vinik A, Hughes MS, Feliberti E, Perry RR, Casellini C, Sinesi M, Vingan H, Johnson L. Carcinoid tumors. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2018. https://www.ncbi.nlm.nih.gov/books/NBK279162/. Vinik A, Hughes MS, Feliberti E, Perry RR, Casellini C, Sinesi M, Vingan H, Johnson L. Carcinoid tumors. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2018. https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK279162/​.
9.
Zurück zum Zitat Alves TG, Kasamatsu TS, Yang JH, Meneghetti MC, Mendes A, Kunii IS, et al. Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay. J Clin Endocrinol Metab. 2016;101(2):653–8.CrossRef Alves TG, Kasamatsu TS, Yang JH, Meneghetti MC, Mendes A, Kunii IS, et al. Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay. J Clin Endocrinol Metab. 2016;101(2):653–8.CrossRef
10.
Zurück zum Zitat Giusti M, Conte L, Repetto AM, Gay S, Marroni P, Mittica M, et al. Detection of polyethylene glycol thyrotropin (TSH) Precipitable percentage (macro-TSH) in patients with a history of thyroid Cancer. Endocrinol Metab (Seoul). 2017;32(4):460–5.CrossRef Giusti M, Conte L, Repetto AM, Gay S, Marroni P, Mittica M, et al. Detection of polyethylene glycol thyrotropin (TSH) Precipitable percentage (macro-TSH) in patients with a history of thyroid Cancer. Endocrinol Metab (Seoul). 2017;32(4):460–5.CrossRef
13.
Zurück zum Zitat Lococo F, Rapicetta C, Casali M, Bellafiore S, Rossi G, Treglia G, et al. 68Ga-DOTATOC PET/CT imaging in solitary fibrous tumor of the pleura. Clin Nucl Med. 2017;42(6):e294–6.CrossRef Lococo F, Rapicetta C, Casali M, Bellafiore S, Rossi G, Treglia G, et al. 68Ga-DOTATOC PET/CT imaging in solitary fibrous tumor of the pleura. Clin Nucl Med. 2017;42(6):e294–6.CrossRef
14.
Zurück zum Zitat Hamidi O, Young WF Jr, Iñiguez-Ariza NM, Kittah NE, Gruber L, Bancos C, et al. Malignant Pheochromocytoma and Paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102(9):3296–305.CrossRef Hamidi O, Young WF Jr, Iñiguez-Ariza NM, Kittah NE, Gruber L, Bancos C, et al. Malignant Pheochromocytoma and Paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102(9):3296–305.CrossRef
15.
Zurück zum Zitat Kong G, Grozinsky-Glasberg S, Hofman MS, Callahan J, Meirovitz A, Maimon O, et al. Efficacy of peptide receptor radionuclide therapy for functional metastatic Paraganglioma and Pheochromocytoma. J Clin Endocrinol Metab. 2017;102(9):3278–87.CrossRef Kong G, Grozinsky-Glasberg S, Hofman MS, Callahan J, Meirovitz A, Maimon O, et al. Efficacy of peptide receptor radionuclide therapy for functional metastatic Paraganglioma and Pheochromocytoma. J Clin Endocrinol Metab. 2017;102(9):3278–87.CrossRef
17.
Zurück zum Zitat Gläsker S, Neumann HPH, Koch CA, Vortmeyer A. Von Hippel-Lindau Disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2018. https://www.ncbi.nlm.nih.gov/pubmed/25905347. Gläsker S, Neumann HPH, Koch CA, Vortmeyer A. Von Hippel-Lindau Disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–2018. https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25905347.
20.
Zurück zum Zitat Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, et al. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2017;102(10):3795–805.CrossRef Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, et al. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2017;102(10):3795–805.CrossRef
22.
Zurück zum Zitat Woltering EA, Wright AE, Stevens MA, Wang YZ, Boudreaux JP, Mamikunian G, et al. Development of effective prophylaxis against intraoperative carcinoid crisis. J Clin Anesth. 2016;32:189–93.CrossRef Woltering EA, Wright AE, Stevens MA, Wang YZ, Boudreaux JP, Mamikunian G, et al. Development of effective prophylaxis against intraoperative carcinoid crisis. J Clin Anesth. 2016;32:189–93.CrossRef
Metadaten
Titel
Neuroendocrine neoplasms – think about it and choose the most appropriate diagnostic and therapeutic steps
verfasst von
Christian A. Koch
S. Petersenn
Publikationsdatum
24.10.2018
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2018
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-018-9472-1

Weitere Artikel der Ausgabe 2/2018

Reviews in Endocrine and Metabolic Disorders 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.